An observational study in Peri-Implantitis, sponsored by Malmö University. Recruiting at 3 sites in 2 countries. Open to participants aged 18 Years to 130 Years. Per ClinicalTrials.gov, last updated 2024-02-16.
Sponsored by Malmö University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Peri-Implantitis with a site in Sweden — 5 open to participants now, 6 under way, none of them phase 3. Peri-Implantitis · Sweden.
Among the 21 studies in Peri-Implantitis with a site in Sweden, this one is one of 2 that started in 2020, is one of 9 observational ones, and was the 15th registered.
324 studies on the registry are indexed under Peri-Implantitis; 89 are open to participants now.
Browse Peri-Implantitis studies →5 of the 21 studies in Peri-Implantitis with a site in Sweden are open now. Recruiting first, the newest first:
Karolinska Institutet · Sites in Sweden
Ages 18+
Koite Health Oy · Sites in Sweden
Ages 18–85
Kristianstad University · Sites in Sweden
Göteborg University · Sites in Sweden
Ages 18+
A study can be open while its sites in Sweden have not opened yet or have stopped. Only those recruiting at a site in Sweden →
Of the 50 Peri-Implantitis studies recruiting now, 28 (56%) set no upper age limit and 9 (18%) stop at 75 or younger; 7 take children under 18; 26 take healthy volunteers.
This study: 18 Years to 130 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2020.
This study's planned enrollment of 650 is above the median of 84 across 122 observational studies indexed under Peri-Implantitis.
Median enrollment 74 across the 12 interventional studies, 41 across the 9 observational. Of the 14 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
7 of 21 have an industry lead sponsor. The 10 most frequent:
Malmö University is the lead sponsor of 44 studies on the registry; 17 are open to participants now.
Malmö University has 3 studies filed under Peri-Implantitis — fewer than ten, so there is no comparison to draw.
3 of the studies in Peri-Implantitis with a site in Sweden that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04847648Göteborg UniversityAir-polishing in the Treatment of Peri-implantitis | 2026-12-15 |
| NCT06648564Kristianstad University20-25 Year Follow-Up on Regenerative Bone Procedures for Peri-Implantitis | 2026-12-31 |
| NCT06017817Koite Health OyAntibacterial Photodynamic Therapy in the Management of Peri-implantitis | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 21 studies in Peri-Implantitis with a site in Sweden, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The surgical treatment outcome of patients that have been or are consecutively treated at the University of Malmö, at Blekinge hospital, and at the Dental Clinic of the Sigmund Freud University Vienna will be evaluated on an a regular base; specifically all patients treated since 2014 and those receiving treatment in the future, will be regularly assessed, max. once per year after the 1-year control from the surgical intervention for clinical and radiographic assessment of healing. Clinical peri-implant parameters (e.g., probing pocket depth) and peri-implant sulcus fluid (PISF) are collected, and a peri-apical radiographic examination is made. Further, from 200 patients treated in the future, the inflammatory peri-implant lesion will be collected and subjected to histological, microbiological, and molecular analysis. The removal of these lesions is a standard procedure and performed in all patients independent of study participation; i.e., the lesion has anyway to be removed during surgery and if the lesions are not stored, they would be thrown.
All patients being treated since 2014 and continuously being treated will be called in for regular check-ups after the surgical intervention and an examination for study purpose will be performed annually.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion criteria:
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 12 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 24 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 36 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 48 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 60 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 72 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 84 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 96 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 108 months postoperative
Disease resolution (Binary: yes/no)
Disease resolution will be defined as peri-implant probing pocket depth ≤ 5 mm and no excessive bleeding and/or suppuration on probing.
Time frame: 120 months postoperative
Started Aug 2020 (actual). Primary completion is estimated for Dec 2030, 124 months after the start.
Of 33 non-industry observational studies under Peri-Implantitis, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 77. This study's planned 124 months is above that.
Counting every sponsor, half of 35 studies reached it within 17 months; a quarter within 8 and three quarters within 77.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Malmö University